Emerging Treatments for Subarachnoid Hemorrhage

Overview

Journal CNS Neurol Disord Drug Targets

Publisher Bentham Science Publishers

Specialties Neurology
Pharmacology

Date 2024 Feb 27

PMID 38409689

Authors

Matthew C Findlay

Mrinmoy Kundu

Jayson R Nelson

Kyril L Cole

Candace Winterton

Samuel Tenhoeve

Brandon Lucke-Wold

Affiliations

Soon will be listed here.

Abstract

The current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a broad overview of the shifting paradigms in SAH care. By synthesizing the historical management protocols with contemporary therapeutic advancements, patient-specific treatment plans can be individualized and optimized to deliver outstanding care for the best possible SAH-related outcomes.

References

Etminan N, Chang H, Hackenberg K, de Rooij N, Vergouwen M, Rinkel G . Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population: A Systematic Review and Meta-analysis. JAMA Neurol. 2019; 76(5):588-597. PMC: 6515606. DOI: 10.1001/jamaneurol.2019.0006. View

Vallee B . [Subarachnoid hemorrhage syndrome and its aneurysmal etiology. From Morgagni to Moniz, Dott and Dandy. A historical overview]. Neurochirurgie. 1998; 44(2):105-10. View

Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S . [Trends in mortality rates for subarachnoid hemorrhage, from 1999 through 2008: single center experience]. No Shinkei Geka. 2010; 38(9):811-5. View

Martin C, Rymer M . Hemorrhagic stroke: aneurysmal subarachnoid hemorrhage. Mo Med. 2011; 108(2):124-7. PMC: 6189155. View

Serrone J, Maekawa H, Tjahjadi M, Hernesniemi J . Aneurysmal subarachnoid hemorrhage: pathobiology, current treatment and future directions. Expert Rev Neurother. 2015; 15(4):367-80. DOI: 10.1586/14737175.2015.1018892. View

Abraham M, Chang W . Subarachnoid Hemorrhage. Emerg Med Clin North Am. 2016; 34(4):901-916. DOI: 10.1016/j.emc.2016.06.011. View

Claassen J, Park S . Spontaneous subarachnoid haemorrhage. Lancet. 2022; 400(10355):846-862. PMC: 9987649. DOI: 10.1016/S0140-6736(22)00938-2. View

Naidech A, Janjua N, Kreiter K, Ostapkovich N, Fitzsimmons B, Parra A . Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 2005; 62(3):410-6. DOI: 10.1001/archneur.62.3.410. View

Hart R, Byer J, Slaughter J, Hewett J, Easton J . Occurrence and implications of seizures in subarachnoid hemorrhage due to ruptured intracranial aneurysms. Neurosurgery. 1981; 8(4):417-21. DOI: 10.1227/00006123-198104000-00002. View

10.

Panczykowski D, Pease M, Zhao Y, Weiner G, Ares W, Crago E . Prophylactic Antiepileptics and Seizure Incidence Following Subarachnoid Hemorrhage: A Propensity Score-Matched Analysis. Stroke. 2016; 47(7):1754-60. PMC: 4927347. DOI: 10.1161/STROKEAHA.116.013766. View

11.

Lindgren A, Vergouwen M, van der Schaaf I, Algra A, Wermer M, Clarke M . Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2018; 8:CD003085. PMC: 6513627. DOI: 10.1002/14651858.CD003085.pub3. View

12.

Kato Y, Kumar A, Chen S . Surgical nuances of clipping after coiling: looking beyond the international subarachnoid aneurysm trial. J Clin Neurosci. 2012; 19(5):638-42. DOI: 10.1016/j.jocn.2011.08.022. View

13.

Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J . International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002; 360(9342):1267-74. DOI: 10.1016/s0140-6736(02)11314-6. View

14.

Geraldini F, De Cassai A, Diana P, Correale C, Boscolo A, Zampirollo S . A Comparison Between Enteral and Intravenous Nimodipine in Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis. Neurocrit Care. 2022; 36(3):1071-1079. DOI: 10.1007/s12028-022-01493-4. View

15.

Maher M, Schweizer T, Loch Macdonald R . Treatment of Spontaneous Subarachnoid Hemorrhage: Guidelines and Gaps. Stroke. 2020; 51(4):1326-1332. DOI: 10.1161/STROKEAHA.119.025997. View

16.

Liu J, Sun C, Wang Y, Nie G, Dong Q, You J . Efficacy of nimodipine in the treatment of subarachnoid hemorrhage: a meta-analysis. Arq Neuropsiquiatr. 2022; 80(7):663-670. PMC: 9685822. DOI: 10.1055/s-0042-1755301. View

17.

Maruhashi T, Higashi Y . An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage. Expert Opin Pharmacother. 2021; 22(12):1601-1614. DOI: 10.1080/14656566.2021.1912013. View

18.

Barfejani A, Rabinstein A, Wijdicks E, Clark S . Poor Utilization of Nimodipine in Aneurysmal Subarachnoid Hemorrhage. J Stroke Cerebrovasc Dis. 2019; 28(8):2155-2158. DOI: 10.1016/j.jstrokecerebrovasdis.2019.04.024. View

19.

Francoeur C, Mayer S . Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care. 2016; 20(1):277. PMC: 5064957. DOI: 10.1186/s13054-016-1447-6. View

20.

Chan V, Lindsay P, McQuiggan J, Zagorski B, Hill M, OKelly C . Declining Admission and Mortality Rates for Subarachnoid Hemorrhage in Canada Between 2004 and 2015. Stroke. 2018; 50(1):181-184. DOI: 10.1161/STROKEAHA.118.022332. View